Disabled-2 inactivation is an early step in ovarian tumorigenicity (Q33863070)

29 July 2017

title

Disabled-2 inactivation is an early step in ovarian tumorigenicity (English)

1 reference

29 July 2017

0 references

Fazili Z

1 reference

29 July 2017

Sun W

1 reference

29 July 2017

Mittelstaedt S

1 reference

29 July 2017

Cohen C

1 reference

29 July 2017

Xu XX

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 May 1999

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

3104-3113

1 reference

Sequence, genomic structure, and chromosomal assignment of human DOC-2.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

Ovarian surface epithelial-stromal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

Human ovarian cancer of the surface epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

A phosphotyrosine interaction domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

Aberrant function of the Ras signal transduction pathway in human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

BRCA1 mutations in primary breast and ovarian carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

Drosophila abl tyrosine kinase in embryonic CNS axons: a role in axonogenesis is revealed through dosage-sensitive interactions with disabled

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

Dosage-sensitive modifiers of Drosophila abl tyrosine kinase function: prospero, a regulator of axonal outgrowth, and disabled, a novel tyrosine kinase substrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

Drosophila abl and genetic redundancy in signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

Mouse disabled (mDab1): a Src binding protein implicated in neuronal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

Neuronal position in the developing brain is regulated by mouse disabled-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

An alternative to SH2 domains for binding tyrosine-phosphorylated proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

Antioncogenes and human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

Molecular cloning of differentially expressed genes in human epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

DOC-2, a candidate tumor suppressor gene in human epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

Identification of a ten-amino acid proline-rich SH3 binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

Scrambler and yotari disrupt the disabled gene and produce a reeler-like phenotype in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

Inherited breast and ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

Aberrant splicing of a mouse disabled homolog, mdab1, in the scrambler mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

Insulin-stimulated disassociation of the SOS-Grb2 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

21 January 2018

Cancer statistics, 1995.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

Orientation of peptide fragments from Sos proteins bound to the N-terminal SH3 domain of Grb2 determined by NMR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

Cloning of a novel phosphoprotein regulated by colony-stimulating factor 1 shares a domain with the Drosophila disabled gene product.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

Genetic Disparity Between Morphologically Benign Cysts Contiguous to Ovarian Carcinomas and Solitary Cystadenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

Cell growth regulation in epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

7 January 2021

Reelin is a secreted glycoprotein recognized by the CR-50 monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

7 January 2021

The biology of ovarian cancer development.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

7 January 2021

Basement membrane structures in tumors of the ovary

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

7 January 2021

A unique pattern of proto-oncogene abnormalities in ovarian adenocarcinomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1202649

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1202649

1 reference

Dimensions Publication ID

29 July 2017

1050723976

0 references

1 reference